NIH Countermeasures Against Chemical Threats (CounterACT) Program Q\u0026A Webinar for R21 and UG3/UH3

(1:6:10)

NIH Countermeasures Against Chemical Threats (CounterACT) Program Cooperative Agreement Q\u0026A Webinar

(57:27)

NIH Countermeasures Against Chemical Threats (CounterACT) Program Cooperative Agreements (U01/U54)

(57:14)

Dr. David Jett, Director, CounterACT

(2:3)

CounterACT Basic Research Informational Webinar

(35:4)

NIH CounterACT Early Stage Investigator Research Award Webinar

(12:5)

Webinar: Biodefense and Infectious Diseases Non-dilutive Funding

(44:26)

Feeling Younger Taking Two Things

(25:5)

14. NIHSS: Extinction and Inattention formerly Neglect

(4:58)

6. NIHSS: Visual

(5:32)

ShmooCon 2014: The NSA: Capabilities and Countermeasures

(52:37)

Formula for Grant Success: CIRM Grant Writing Webinar

(1:14)

החזן הראשי חיים אדלר ובנו ישראל אדלר - רחמנו טאטע | Chazan Chaim Adler and son Yisrael Adler

(6:32)

Postbac Life: Lindsey Jay Demonstrates the Microtome

(3:19)

The broad impact of innate immune receptors in viral infection, cancer and autoimmunity

(1:7:37)

What is ionizing radiation?

(2:32)

Expedition 64 Inflight with National Institutes of Health - March 26, 2021

(22:2)

Manufacturing medical countermeasures against catastrophic biothreats | Daniel Gastfriend

(28:34)

BARDA Medical Countermeasures Director Dr. Robert Johnson, 18th Non-Dilutive Funding Summit (2023)

(38:31)

NIH SciBites: Mapping Brain Highways to Stop Substance Use Disorders

(2:11)

Nuclear Watch: Radiation and nuclear countermeasures program overview 1/27/2014

(2:25:39)

Accelerating COVID-19 Therapeutic Interventions \u0026 Vaccines (ACTIV)

(6:24)

National Institutes of Health (NIH)

(13:47)

NIH Clinical Trials: #COVID19 ACTIV-4 Antithrombotics

(1:4)

Biodefense and Infectious Diseases Funding Opportunities

(36:6)

NCATS: NIH: Translating Disruptive Technologies from Microphysiological Systems to Electronic Noses

(51:13)

Thomas Denny - Establishment of a Duke NUS/DHVI Center for Countermeasures to Emerging Infections

(21:8)

Inside NIH Study Sections and Common Mistakes Seen on Applications

(44:10)

Improving Medical Countermeasures for Acute Intoxication with Seizurogenic Chemical Threat Agents

(57:30)